RCIM
Red Cedar Investment Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.05M | Hold |
27,210
| – | – | 0.64% | 28 |
|
|
2025
Q1 | $5.7M | Hold |
27,210
| – | – | 0.79% | 19 |
|
|
2024
Q4 | $4.84M | Sell |
27,210
-8,717
| -24% | -$1.55M | 0.61% | 23 |
|
|
2024
Q3 | $7.09M | Hold |
35,927
| – | – | 0.9% | 17 |
|
|
2024
Q2 | $6.16M | Hold |
35,927
| – | – | 0.84% | 18 |
|
|
2024
Q1 | $6.54M | Buy |
35,927
+3,035
| +9% | +$553K | 0.82% | 19 |
|
|
2023
Q4 | $5.1M | Hold |
32,892
| – | – | 0.73% | 22 |
|
|
2023
Q3 | $4.9M | Buy |
32,892
+308
| +0.9% | +$45.9K | 0.75% | 18 |
|
|
2023
Q2 | $4.39M | Hold |
32,584
| – | – | 0.67% | 22 |
|
|
2023
Q1 | $5.19M | Buy |
32,584
+10,517
| +48% | +$1.68M | 0.8% | 16 |
|
|
2022
Q4 | $3.57M | Buy |
22,067
+1,555
| +8% | +$251K | 0.56% | 24 |
|
|
2022
Q3 | $2.75M | Buy |
20,512
+2,186
| +12% | +$293K | 0.47% | 27 |
|
|
2022
Q2 | $2.81M | Sell |
18,326
-4,114
| -18% | -$630K | 0.46% | 27 |
|
|
2022
Q1 | $3.64M | Buy |
22,440
+2,955
| +15% | +$479K | 0.51% | 26 |
|
|
2021
Q4 | $2.64M | Hold |
19,485
| – | – | 0.32% | 35 |
|
|
2021
Q3 | $2.1M | Buy |
19,485
+3,273
| +20% | +$353K | 0.27% | 31 |
|
|
2021
Q2 | $1.83M | Sell |
16,212
-3,273
| -17% | -$369K | 0.24% | 37 |
|
|
2021
Q1 | $2.11M | Hold |
19,485
| – | – | 0.27% | 34 |
|
|
2020
Q4 | $2.09M | Buy |
19,485
+16,399
| +531% | +$1.76M | 0.31% | 31 |
|
|
2020
Q3 | $270K | Buy |
+3,086
| New | +$270K | 0.05% | 71 |
|